![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Regenerate: a phase 3, double-blind, randomized, placebo-controlled
multicenter study of obeticholic acid therapy for nonalcoholic steatohepatitis
|
|
|
Reported by Jules Levin
EASL Conference: NASH Beyond the Acronym,
Certainties and Clinical Dilemmas 2016,
May 12-14 2016, Riga, Latvia
![0705171](../images/070517/072517-3/0705171.gif)
![0705172](../images/070517/072517-3/0705172.gif)
![0705173](../images/070517/072517-3/0705173.gif)
![0705174](../images/070517/072517-3/0705174.gif)
![0705175](../images/070517/072517-3/0705175.gif)
![0705176](../images/070517/072517-3/0705176.gif)
![0705177](../images/070517/072517-3/0705177.gif)
![0705178](../images/070517/072517-3/0705178.gif)
![0705179](../images/070517/072517-3/0705179.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|